Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 5,181,767 |
|
|||||
| News | - | ||||||
| Day High | 124.54 | Low High |
|||||
| Day Low | 122.46 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.75 | -0.61% | 122.00 | 18:30:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 123.55 | 122.46 | 124.54 | 122.71 | 122.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 64,828 | 5,181,767 | $ 123.35 | $ 639,151,269 | - | 75.56 - 138.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:34:16 | 1 | $ 122.355 | USD |
Novo Nordisk (NVO) Options Flow Summary
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 552.48B | 4.51B | - | 232.26B | 83.68B | 18.56 | 6.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 126.74 | 127.06 | 121.79 | 123.89 | 3,038,323 | -4.74 | -3.74% |
| 1 Month | 129.22 | 130.25 | 121.79 | 126.24 | 3,399,264 | -7.22 | -5.59% |
| 3 Months | 106.53 | 138.28 | 106.42 | 124.58 | 5,114,345 | 15.47 | 14.52% |
| 6 Months | 98.77 | 138.28 | 92.94 | 113.44 | 4,565,029 | 23.23 | 23.52% |
| 1 Year | 81.91 | 138.28 | 75.56 | 105.78 | 3,403,987 | 40.09 | 48.94% |
| 3 Years | 36.38 | 138.28 | 36.195 | 83.81 | 1,999,630 | 85.62 | 235.35% |
| 5 Years | 24.23 | 138.28 | 23.00 | 66.69 | 1,758,716 | 97.77 | 403.51% |
Novo Nordisk Description
| Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
